Small molecule drug companies develop low-molecular-weight medicines designed to interact with specific biological targets. These compounds can often enter cells and may be formulated as oral or other conventional dosage forms across a wide range of therapeutic areas.
This category includes companies working on:
Browse 202 UK small molecule drug companies below.
Regulatory affairs, quality assurance and clinical development consulting
G&L Scientific is a Belfast-founded regulatory affairs and quality assurance consultancy providing integrated product development and market access services to pharmaceutical,…
Academic drug discovery accelerator developing small molecule therapeutics
Slingshot Therapeutics is a drug discovery accelerator that identifies early-stage scientific programmes from academic institutions and advances them towards clinical development.…
Light-activated small molecule therapies for oral cancer and wound care
LightOx is a biotechnology company developing light-activated small molecule therapeutics for cancer and infection. Its lead candidate LXD191 is a topically applied…
Cannabinoid medicines, neuroscience and oncology drug development
Jazz Pharmaceuticals is a global biopharmaceutical company focused on medicines for neuroscience and oncology. Its UK operations, centred at Kent Science Park in Sittingbourne,…
Pharmaceutical company in cardiometabolic, oncology, and immunology
Eli Lilly and Company is a multinational pharmaceutical company with UK operations headquartered in Basingstoke and an R&D site in Bracknell. Founded in 1876, Lilly's UK affiliate…
Small molecule drugs targeting intrinsically disordered proteins in cancer
Kodiform Therapeutics is a drug discovery company developing first-in-class small molecule inhibitors against intrinsically disordered protein targets in cancer, a class…
Anti-virulence drug discovery from natural bioactive compounds
Neem Biotech is a Wales-based drug discovery company developing novel non-traditional antimicrobial treatments derived from naturally inspired compounds. The company specialises…
AI-enabled small molecule drug discovery
PharmEnable is a Cambridge-based drug discovery company developing novel small molecule therapeutics for targets that are inaccessible to biologics, including intracellular…
Clinical-stage anti-infectives targeting antimicrobial resistance and infectious disease
NovaBiotics is a clinical-stage biotechnology company developing first-in-class anti-infective therapies for difficult-to-treat infectious diseases, with a focus on antimicrobial…
Small molecule theranostics to improve transplant outcomes
Kairos Biotech is an early-stage biotechnology company developing proprietary small molecules and nanoscale-engineered binders for application in transplant diagnostics and…
Biopharmaceutics and dissolution consultancy for drug product development
Biowaived is a contract research organisation providing biopharmaceutics and dissolution expertise to pharmaceutical and biotechnology companies. The company offers consultancy…
AI-driven natural product discovery for neurological therapeutics
Pangea Bio is a clinical-stage biotechnology company developing small molecule therapeutics for neurological and neuropsychiatric disorders. Its proprietary AI platform screens…